Primary anti-retroviral resistance in treatment-naive HIV-infected patients: A Korean HIV/AIDS Cohort Study
Song JY, Lee JS, Jung HW, et al.: Primary anti-retroviral resistance in treatment-naive HIV-infected patients: A Korean HIV/AIDS Cohort Study. Infect Chemother 2009;41(4):230-232.
Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China
Chin BS, Choi JY, Han Y, et al.: Comparison of genotypic resistance mutations in treatment-naive HIV type 1-infected patients in Korea and China. AIDS Res Hum Retroviruses 2010;26(2):217-221.
Low prevalence of drugresistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea
Kim CO, Chin BS, Han SH, et al.: Low prevalence of drugresistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea. Tohoku J Exp Med 2008;216(3): 259-265.
Resistanceassociated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01-AE
Praparattanapan J, Kotarathitithum W, Chaiwarith R, Nuntachit N, Sirisanthana T, and Supparatpinyo KL: Resistanceassociated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01-AE. Curr HIV Res 2012;10(8):647-652.
Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients
Kuritzkes DR, Quinn JB, Benoit SL, et al.: Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. AIDS 1996;10(9):975-981.
Antiretroviral genotypic resistance mutations in HIV-1 infected Korean patients with virologic failure
Chin BS, Choi J-Y, Choi JY, et al.: Antiretroviral genotypic resistance mutations in HIV-1 infected Korean patients with virologic failure. J Korean Med Sci 2009;24(6):1031-1037.